Related Experiment Video
Updated: Aug 6, 2026

09:03
Forward Genetic Approaches in Chlamydia trachomatis
Published on: October 23, 2013
Summary
Pristinamycin effectively combats Chlamydia psittaci in mice at a therapeutic dose. This antibiotic shows promise for treating Chlamydia trachomatis and sexually transmitted infections.
Area of Science:
- Microbiology
- Pharmacology
Context:
- Chlamydia psittaci and Chlamydia trachomatis are significant bacterial pathogens.
- Pristinamycin is an antibiotic with potential antimicrobial properties.
Purpose:
- To evaluate the in vitro and in vivo efficacy of pristinamycin against Chlamydia psittaci.
- To determine the therapeutic dosage of pristinamycin for Chlamydia infections.
Summary:
- In vitro studies showed pristinamycin's activity against C. psittaci and C. trachomatis at low concentrations.
- In vivo studies in mice infected with C. psittaci demonstrated that a 100 mg/kg dosage of pristinamycin was therapeutic, reducing mortality.
- The antibiotic was found to be active at the 100 mg/kg dosage, which is considered the therapeutic dosage.
Impact:
- Pristinamycin exhibits therapeutic potential for Chlamydia infections.
- Further research into pristinamycin for treating sexually transmitted diseases, including gonorrhea, is warranted.
Related Concept Videos
Sexually Transmitted Infections
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Antimicrobial Effectiveness
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Bacterial Phylum Chlamydiae
The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic of...
Trichomoniasis
Trichomonas vaginalis is a flagellated protozoan parasite and the causative agent of trichomoniasis, one of the most prevalent non-viral sexually transmitted infections in the United States. This extracellular parasite primarily colonizes the lower genitourinary tract in women—particularly the vagina—and in men, the urethra and prostate. Its structural and functional adaptations enable its survival, motility, and pathogenicity within the host environment.Structural Features and Host EntryT.
Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...

